← SynDRA
ROFECOXIB
SynDRA canonical compound SYN0001092 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · OTC |
| Primary target(s) | PTGS2 |
| Mechanism of action | Cyclooxygenase inhibitor |
All known targets
- PTGS2
- CYP3A4
- ELN
- MT-CO2
- PTGER2
- PTGS1
- Ptgs1
- Ptgs2
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- vioxx
- ceeoxx
- M01AH02
- MK-0966
- MK-966
- MK0966
- NSC-720256
- NSC-758705
- TRM-201
- TRM201
- Vioxx
- Ceoxx
- Refecoxib
- Cahill May Roberts brand of rofecoxib
- MSD brand of rofecoxib
- Merck Frosst brandof rofecoxib
- Merck brand of rofecoxib
- Vioxx Dolor
- MK 0996
- Ceeoxx (TN)
- Ceoxx (TN)
- KS-1107
- Merck Sharp & Dhome brand of rofecoxib
- Vioxx (TN)
- Vioxx (trademark)
- Rofecoxib (JAN/USAN/INN)
- 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
- 3-Phenyl-4-(4-(methylsulfonyl)phenyl))-2(5H)-furanone
- 3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone
- 4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
- 4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one
- 4-(p-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
- 4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
- 4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
- 4-(4-(Methylsulfonyl)phenyl)-3-phenylfuran-2(5H)-one
- MK 0966
- rofecoxibum
- 0QTW8Z7MCR
Look up ROFECOXIB in the interactive SynDRA portal →